Trials / Unknown
UnknownNCT05571436
iCan Diabetes Self-management and Prevention Program
iCan Diabetes Self-Management and Prevention Support Group
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the feasibility and preliminary efficacy of the iCan Diabetes Self-Management and Prevention Support Group using a single arm clinical trial. The program is composed of six weekly sessions, and it will be implemented with 60 adults (aged 18 years or older) who have been diagnosed with type 2 diabetes or prediabetes and evaluated using mixed methods. A pre-test will be conducted before the program implementation and a post-test will be conducted three months after the pre-test. Focus groups will be conducted shortly after the last session to obtain feedback on the program. Between the last session and the post-test, weekly emails/texts will be sent to keep participants engaged and maximize retention rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | iCan Diabetes Self-management and Prevention Support Group | Participants will be asked to attend six weekly sessions and complete pre-and post-assessments with an optional focus group. The intervention will cover the following topics: 1) Yes, iCan! - Affirmations and Empowerment, 2) The Language of Diabetes - Diabetes Synopsis, 3) Diabetes and Me - Management Strategies, 4) Extraordinary Health - Dream Team, 5) Food for Thought - Food Conscious, and 6) Discussion - Stories/Goals. Each session is composed of a Check-in, Affirmation/Empowerment Activity, Short Presentation, Q\&A and Discussion, Goal setting, and Testing Healthy Snacks. |
Timeline
- Start date
- 2022-10-17
- Primary completion
- 2023-06-30
- Completion
- 2023-08-30
- First posted
- 2022-10-07
- Last updated
- 2022-10-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05571436. Inclusion in this directory is not an endorsement.